Calcium and vitamin D have long been the headline nutrients for bone health. Increasingly, however, nutrition scientists and consumers are paying attention to a lesser-known partner: vitamin K2. This fat-soluble vitamin helps direct calcium to the bones and teeth, where it is needed, and away from arteries and soft tissues, where it can cause problems. As awareness of its role in bone and cardiovascular health grows, vitamin K2 is moving from a niche ingredient to a mainstream part of the supplement and functional food market.

Vitamin K2 Market Size and Forecast

According to Polaris Market Research, the global vitamin K2 market was valued at USD 157.49 million in 2025. The market is expected to reach USD 178.51 million in 2026 and USD 496.43 million by 2034, growing at a CAGR of 13.61% from 2026 to 2034. This strong growth reflects rising consumer interest in preventive health and evidence-backed nutrients.

What Is Vitamin K2?

Vitamin K exists in two main natural forms: vitamin K1, found mainly in leafy green vegetables, and vitamin K2, found in fermented foods and some animal products. Vitamin K2 itself comes in several forms called menaquinones, of which MK-4 and MK-7 are the most studied. MK-7 has a longer half-life in the body, which means it stays active longer and can be taken in smaller doses. A common natural source of MK-7 is natto, a traditional Japanese food made from fermented soybeans. Today, many consumers choose a vitamin K2 supplement to get consistent daily intake, often combined with vitamin D3 and calcium.

Key Market Drivers

Rising Demand for Bone Health Supplements

Osteoporosis and low bone density are major health concerns, especially among older adults and postmenopausal women. As populations age and awareness of bone health increases, consumers are seeking supplements that support bone strength. Vitamin K2 activates proteins that help bind calcium to bone, making it a valuable addition to bone health formulations.

Preference for Natural and Plant-Based Sources

Consumers increasingly prefer natural, plant-based ingredients. Vitamin K2 derived from fermented soy, such as natto-based MK-7, fits well with clean-label and vegan-friendly product trends. This preference is encouraging manufacturers to invest in natural fermentation-based production.

Expansion into Functional Foods and Beverages

Vitamin K2 is no longer limited to capsules and tablets. Food and beverage manufacturers are adding it to fortified dairy products, plant-based milks, nutrition bars and beverages. This expands the reach of vitamin K2 to consumers who may not take traditional supplements.

Segment Insights

Polaris Market Research segments the vitamin K2 market by product type, source, form and application. By product type, MK-7 accounted for 45.0% of the market in 2025, reflecting its long half-life and strong research base. MK-4 and combination products make up the remaining product categories.

By source, natural vitamin K2 held a 62.0% share in 2025, supported by consumer demand for naturally derived ingredients. Synthetic vitamin K2 offers consistency and scalability for manufacturers.

By form, capsules and tablets accounted for 62.0% of the market in 2025, as they remain the most familiar and convenient supplement formats. Powder is the fastest-growing form, with a projected CAGR of 15.20%, as it is easy to blend into food, beverages and multi-ingredient formulations.

By application, food and pharmaceutical uses held a 58.0% share in 2025. The nutraceutical segment is projected to grow fastest, at a CAGR of 15.46%, driven by the expansion of the dietary supplement industry.

Browse In-depth Market Research Report:

https://www.polarismarketresearch.com/industry-analysis/vitamin-k2-market 

Regional Analysis

North America led the global vitamin K2 market with a 35.0% share in 2025. High supplement usage, strong consumer awareness of bone and heart health, and a well-developed nutraceutical industry support the region's position. Europe also has a strong market, with growing scientific interest in vitamin K2 and its role in cardiovascular health. Asia Pacific is expected to see strong growth, supported by Japan's long tradition of natto consumption and rising health awareness across the region.

Research and Consumer Education

Ongoing research into vitamin K2's role in bone health, arterial health and other areas continues to strengthen its credibility. However, many consumers are still unfamiliar with the difference between vitamin K1 and K2. Education by brands, healthcare professionals and nutrition experts will be important in expanding awareness and driving adoption.

Competitive Landscape

Key players covered in the Polaris Market Research report include NattoPharma, Kappa Bioscience, DSM Nutritional Products, Gnosis by Lesaffre, Zhejiang Medicine Co., Ltd. and Sports Research Corporation. These companies are focused on high-purity production, clinical research, branded ingredients and partnerships with supplement and food brands.

Key Companies

• NattoPharma
• Kappa Bioscience
• DSM Nutritional Products
• Gnosis by Lesaffre
• Zhejiang Medicine Co., Ltd.
• Sports Research Corporation
• NOW Foods
• MaryRuth Organics
• Herbalife Nutrition
• Nature's Way
• Life Extension
• Longlife
• Green Valley
• Vital Nutrients

Future Outlook

Vitamin K2 is set to become a core nutrient in bone and cardiovascular health products. With rising consumer interest, expanding applications and growing scientific support, the market is expected to grow strongly through 2034. Ingredient suppliers and brands that invest in quality, research and consumer education will be best positioned to benefit.

More Trending Latest Reports By Polaris Market Research:

Erythropoietin Drugs Market Trends

Digital Content Creation Market Size

Home Water Filtration Market Share

Wearable Technology Market Growth

Private Nursing Services Market Forecast

Tuna Fish Market Analysis

Soil Treatment Market Opportunities

Road Safety Market Trends

EMI Shielding Market Size